-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OHXExuVU/upsNiauBxGFKSS/G9u943PosFq290b5Y2Dfjc6U4zF10mg1C9cDsRwN pViRM+/foFTILzqMmgDV3A== 0000874716-06-000057.txt : 20060502 0000874716-06-000057.hdr.sgml : 20060502 20060502141544 ACCESSION NUMBER: 0000874716-06-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060428 FILED AS OF DATE: 20060502 DATE AS OF CHANGE: 20060502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MURRAY ROBERT J CENTRAL INDEX KEY: 0001038684 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 06798749 BUSINESS ADDRESS: BUSINESS PHONE: 9784486111 MAIL ADDRESS: STREET 1: C/O NEW ENGLAND BUSINESS SERVICE INC STREET 2: 500 MAIN STREET CITY: GROTON STATE: MA ZIP: 01471 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2078560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2006-04-28 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001038684 MURRAY ROBERT J C/O IDEXX LABORATORIES, INC ONE IDEXX DRIVE WESTBROOK ME 04092 1 0 0 0 Common Stock 2006-04-28 4 A 0 111 83.21 A 10590 D Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units acquired is determined by dividing the amount of Director's cash compensation deferred pursuant to the Plan ($9,250) by the closing price of the IDEXX Laboratories, Inc. Common Stock on the date of the deferral. Deferred stock units are issuable only as common stock on a one-for-one basis one year following the Director's resignation from the Board of Directors. Conan R. Deady, Attorney-in-Fact for Robert J. Murray 2006-05-02 -----END PRIVACY-ENHANCED MESSAGE-----